Results 131 to 140 of about 31,483 (223)

Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. [PDF]

Life (Basel)
Mihaljević D, Sitaš Z, Hanulak J, Vranjić P, Mihaljević J.   +4 more
europepmc   +1 more source

The Global Landscape of <i>Plasmodium falciparum</i> Drug Resistance Markers, 2005-2025: A Systematic Review and Meta-Analysis. [PDF]

Pathogens
Habarugira F, Batamuriza J, Ndahimana R, Minega JN, Dieng MM, Mutsaka-Makuvaza MJ, Daba TM, Idaghdour Y, Mutesa L.   +8 more
europepmc   +1 more source

Synergistic activity of RSL3 and Pyrimethamine to inhibit the proliferation of Plasmodium falciparum. [PDF]

Antimicrob Agents Chemother
Nikolova V, Linnemannstöns K, Zahoruiko A, Ganter M, Lüder CG, Dobbelstein M.   +5 more
europepmc   +1 more source

Prevalence of antimalarial drug resistance molecular markers in Makenene, central Cameroon. [PDF]

Int J Parasitol Drugs Drug Resist
Kala-Chouakeu NA, Djoufounna J, Benoit N, Tchuinkam T, Delandre O, Almeras L, Bamou R, Antonio-Nkondjio C, Madamet M, Pradines B.   +9 more
europepmc   +1 more source

Intravitreal cotrimoxazole as adjuvant therapy for active ocular toxoplasmosis: a case series and literature review. [PDF]

J Ophthalmic Inflamm Infect
Hosseini SM, Azadmanesh A, Zamani G, Shariati MM.   +3 more
europepmc   +1 more source

Whole genome sequencing to inform the epidemiology of Plasmodium falciparum malaria in the elimination setting of Malaysia. [PDF]

BMC Genomics
Tan MKI, Billows N, Divis PCS, Daneshvar C, Edgeworth J, Singh JC, Campino S, Clark TG.   +7 more
europepmc   +1 more source

Inequalities in the use of three-dose of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine among women in Sierra Leone, 2008-2019. [PDF]

Malar J
Osborne A, Bai-Sesay AU, Sesay U, Bangura C, Ahinkorah BO.   +4 more
europepmc   +1 more source

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]

Emerg Infect Dis
Niyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J.   +25 more
europepmc   +1 more source

Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in Uganda. [PDF]

Int J Epidemiol
Adrama H, Dela Cruz EJ, Ozarslan N, Kakuru A, Odongo B, Gaw SL, Benjamin-Chung J, Kizza J, Aguti M, Ategeka J, Olwoch P, Nakalembe M, Opira B, Clark TD, Kamya MR, Rosenthal PJ, Dorsey G, Roh ME.   +17 more
europepmc   +1 more source

Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad. [PDF]

Malar J
Grandesso F, Diar MSI, Kouassi F, Sayyad-Hilario J, Ouedraogo P, Djimde AA, Singh S, Dama S.   +7 more
europepmc   +1 more source